183 related articles for article (PubMed ID: 11021818)
1. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
Zhang Q; Raghunath PN; Vonderheid E; Odum N; Wasik MA
Am J Pathol; 2000 Oct; 157(4):1137-46. PubMed ID: 11021818
[TBL] [Abstract][Full Text] [Related]
2. SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78: implications in JAK3-mediated signaling.
León F; Cespón C; Franco A; Lombardía M; Roldán E; Escribano L; Harto A; González-Porqué P; Roy G
Leukemia; 2002 Aug; 16(8):1470-7. PubMed ID: 12145687
[TBL] [Abstract][Full Text] [Related]
3. Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
Nagasawa T; Zhang Q; Raghunath PN; Wong HY; El-Salem M; Szallasi A; Marzec M; Gimotty P; Rook AH; Vonderheid EC; Odum N; Wasik MA
Leuk Res; 2006 Mar; 30(3):303-12. PubMed ID: 16185764
[TBL] [Abstract][Full Text] [Related]
4. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain.
Adachi M; Ishino M; Torigoe T; Minami Y; Matozaki T; Miyazaki T; Taniguchi T; Hinoda Y; Imai K
Oncogene; 1997 Apr; 14(13):1629-33. PubMed ID: 9129156
[TBL] [Abstract][Full Text] [Related]
6. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
7. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
8. Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells. Implications for lymphomagenesis.
Ma XZ; Jin T; Sakac D; Fahim S; Zhang X; Katsman Y; Bali M; Branch DR
Exp Hematol; 2003 Feb; 31(2):131-42. PubMed ID: 12591278
[TBL] [Abstract][Full Text] [Related]
9. The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera.
Asimakopoulos FA; Hinshelwood S; Gilbert JG; Delibrias CC; Göttgens B; Fearon DT; Green AR
Oncogene; 1997 Mar; 14(10):1215-22. PubMed ID: 9121771
[TBL] [Abstract][Full Text] [Related]
10. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
11. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
Gadina M; Sudarshan C; O'Shea JJ
J Immunol; 1999 Feb; 162(4):2081-6. PubMed ID: 9973481
[TBL] [Abstract][Full Text] [Related]
12. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.
Zhang Q; Wang HY; Marzec M; Raghunath PN; Nagasawa T; Wasik MA
Proc Natl Acad Sci U S A; 2005 May; 102(19):6948-53. PubMed ID: 15870198
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells.
Nakase K; Cheng J; Zhu Q; Marasco WA
J Leukoc Biol; 2009 Jan; 85(1):165-74. PubMed ID: 18948549
[TBL] [Abstract][Full Text] [Related]
14. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
Nakamura K; Cambier JC
J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
[TBL] [Abstract][Full Text] [Related]
15. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
Wheadon H; Edmead C; Welham MJ
Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
[TBL] [Abstract][Full Text] [Related]
16. SHP-1 suppresses cancer cell growth by promoting degradation of JAK kinases.
Wu C; Guan Q; Wang Y; Zhao ZJ; Zhou GW
J Cell Biochem; 2003 Dec; 90(5):1026-37. PubMed ID: 14624462
[TBL] [Abstract][Full Text] [Related]
17. The function of the protein tyrosine phosphatase SHP-1 in cancer.
Wu C; Sun M; Liu L; Zhou GW
Gene; 2003 Mar; 306():1-12. PubMed ID: 12657462
[TBL] [Abstract][Full Text] [Related]
18. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
20. Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role.
Gadina M; Stancato LM; Bacon CM; Larner AC; O'Shea JJ
J Immunol; 1998 May; 160(10):4657-61. PubMed ID: 9590209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]